Search results
Edgewise gets EU orphan drug status for muscular dystrophy drug (NASDAQ:EWTX)
Seeking Alpha· 3 hours agoEdgewise Therapeutics (EWTX) has received orphan drug designation from EU regulators for sevasemten...
Edgewise Therapeutics (EWTX) has received orphan drug designation from EU regulators for sevasemten...